- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Retinal Vein Occlusion (RVO) in Japan
Total 22 results
-
Kyoto University, Graduate School of MedicineNovartisUnknown
-
Tokyo Medical UniversityUnknownCentral Retinal Vein Occlusion | Macular Edema | Branch Retinal Vein OcclusionJapan
-
Fukushima Medical UniversityUnknown
-
Novartis PharmaceuticalsCompletedMacular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)Japan
-
Nagoya City UniversityNovartisCompletedBranch Retinal Vein OcclusionJapan
-
Mie UniversityUnknownCentral Retinal Vein OcclusionJapan
-
Santen Pharmaceutical Co., Ltd.CompletedMacular Edema Following Branch Retinal Vein OcclusionJapan, Korea, Republic of
-
Sanwa Kagaku Kenkyusho Co., Ltd.CompletedMacular Degeneration | Macular Edema | Branch Retinal Vein OcclusionJapan
-
Shinjo Ophthalmologic InstituteCompleted
-
BayerRegeneron PharmaceuticalsCompleted
-
Hoffmann-La RocheChugai PharmaceuticalCompletedCentral Retinal Vein Occlusion | Macular Edema | Hemiretinal Vein OcclusionUnited States, Korea, Republic of, Brazil, Japan, United Kingdom, China, Argentina, Australia, France, Hungary, Italy, Poland, Spain, Singapore, Austria, Czechia, Germany, Hong Kong, Israel, Portugal, Russian Federation, Taiwan
-
Regeneron PharmaceuticalsBayerCompletedBranch Retinal Vein OcclusionUnited States, Japan, Canada
-
Hoffmann-La RocheChugai PharmaceuticalCompletedMacular Edema | Branch Retinal Vein OcclusionUnited States, Korea, Republic of, Brazil, Japan, United Kingdom, China, Argentina, Australia, France, Germany, Hungary, Italy, Poland, Spain, Singapore, Austria, Czechia, Hong Kong, Israel, Portugal, Russian Federation, Taiwan
-
Novartis PharmaceuticalsCompletedRetinal Vein OcclusionJapan
-
Novartis PharmaceuticalsTerminatedCentral Retinal Vein OcclusionChina, Czechia, Germany, Russian Federation, Turkey, United States, Australia, Canada, Spain, United Kingdom, Thailand, Israel, Netherlands, Italy, Hungary, France, Greece, Puerto Rico, Malaysia, Japan
-
Novartis PharmaceuticalsTerminatedBranch Retinal Vein OcclusionChina, Austria, Czechia, Russian Federation, Taiwan, United Kingdom, Canada, Japan, United States, France, Israel, Germany, Italy, Hong Kong, Spain, Denmark, Slovakia, Puerto Rico, Switzerland
-
BayerRegeneron PharmaceuticalsRecruitingMacular Edema Secondary to Retinal Vein OcclusionJapan, Korea, Republic of, China, Israel, Lithuania, United States, Italy, Spain, Hungary, Portugal, Serbia, Poland, United Kingdom, Thailand, Czechia, Austria, Germany, Turkey, Australia, Bulgaria, Estonia, France, Georgia, Latvia, Mal... and more
-
BayerRegeneron PharmaceuticalsCompletedRetinal Vein OcclusionItaly, Korea, Republic of, France, Germany, Australia, Austria, Singapore, Hungary, Latvia, Japan
-
Novartis PharmaceuticalsCompletedDiabetic Macular Edema | Retinal Vein Occlusion | Wet Age Related Macular Degeneration | Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein OcclusionSpain, China, Colombia, Korea, Republic of, Belgium, Greece, Japan, Russian Federation, Turkey, United Kingdom, Egypt, Germany, Australia, Canada, France, Austria, Hong Kong, Hungary, Israel, Netherlands, Peru, Singapore, Slovakia, Sl... and more
-
University of ShizuokaHamamatsu University; Maruyama Memorial General HospitalCompletedAtherosclerosis | Hemodialysis | Chronic Renal FailureJapan
-
Kumamoto UniversityActive, not recruitingCoronary Artery Disease | End Stage Renal DiseaseJapan
-
MedtronicRecruitingCoronary Artery Disease | Renal Insufficiency | Neurological Disorders | Intracranial Aneurysm | Surgical Procedures, Operative | Respiratory Therapy | Minimally Invasive Surgical Procedures | Cardiac Rhythm Disorders | Urological Disorders | Cardiovascular Disorders | Digestive Disorders | Mechanical Circulatory... and other conditionsChina, France, Italy, United States, Spain, Australia, Belgium, Denmark, Germany, Greece, Hungary, Israel, Japan, Korea, Republic of, Malaysia, Netherlands, Norway, Portugal, Serbia, Sweden, Switzerland, United Kingdom, Argentina, Brazil and more